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Since the dramatic decrease in the incidence of
septic abortion in industrialized countries, acute
renal failure (ARF) complicating pregnancy repre-
sents a small percentage of the cases of acute renal
shutdown, falling in France from 40% in 1966 to
4.5% in 1978 [1]. It is underlined in most series that
the mortality rate in ARF associated with pregnancy
is lower than that observed in nonobstetric ARF. In
their recent survey, Cameron and Brown reported
that it ranged from 9 to 34% [2]. This is probably
explained by the young age of the patients and, in
the most recent studies, also by the earlier detection
of the underlying obstetric complications and their
better management. Chapman and Legrain in-
dicated that in the Department of Obstetrics at the
Foch Hospital in Suresnes, France, no case of acute
renal failure was observed among 12,000 delivered
women, including 5 with eclampsia and 25 with
abruptio placentae [1]. In their large study of 154
women with eclampsia, Pritchard and Pritchard
noted only one case of ARF [3].
In contrast with these relatively optimistic data,
ARF in pregnancy bears a high risk of bilateral
renal cortical necrosis (BRCN), and consequently
of chronic renal failure. In 1972, Kleinknecht et al
found that the incidence of BRCN was 21% in post-
partum renal failure, whereas it was only 1.5% in
postabortum ARF. Among 38 cases of BRCN, 26
(68%) were of obstetric origin [4].
In addition to the classical renal complications of
p'regnancy, idiopathic postpartum ARF has been
recognized for the last decade [5]. It often leads to
irreversible renal failure and is associated with a
high mortality rate. The pathogenesis of this syn-
drome remains to be elucidated, and its relationship
to the idiopathic hemolytic uremic syndrome and
thrombotic thrombocytopenic purpura is still debat-
ed[5].
The present review is based on the data in the
literature and on our own experience with 57 cases
of ARF related to pregnancy, referred to the Neck-
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er Hospital from 1957 to 1979 (including 47 cases
after 1966). Some patients were included in a pre-
vious paper from our clinic [4]. Patients with septic
abortion were excluded. The main clinical and path-
ologic features are summarized in Table 1. The cir-
cumstances leading to ARF are listed in Table 2.
The overall maternal mortality rate was 14% (Table
2).
Acute renal failure due to factors not specific of pregnancy
In our experience this group of patients is charac-
terized by good maternal prognosis because neither
maternal death nor BRCN occurred.
Prerenal azotemia secondary to sodium and wa-
ter loss. Hyperemesis gravidarum and late vomiting
of pregnancy may lead to renal disorders, including
ARF [6]. This syndrome was often accompanied by
kaliopenia resulting in vacuolar renal tubular
changes [7]. At present, precise and early correc-
tion of water and electrolyte balance should prevent
severe renal disturbances.
Acute pyeionephritis and other sepsis. The in-
cidence of acute pyelonephritis is high in preg-
nancy, occurring in 1 to 2% of all gravidas, and its
severity has long been emphasized, even in the
most recent studies [8]. The incidence of severe
uremia was, however, relatively low. Ober et al, in
their survey extending from 1931 to 1954 in Boston,
found 8 cases of acute pyelonephritis with uremia
leading to death [7]. Hamburger et al at the Necker
Hospital observed 2 gravidas with acute pyelone-
phritis and ARF from 1951 to 1963 [9]. In earlier
reports, before the use of antibiotics, severe acute
pyelonephritis was occasionally complicated by
renal vein thrombosis [10, Il], but this complication
did not appear more frequently in pregnant women.
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course of severe preeclampsia, but its incidence is
at present low, probably because of earlier and
more appropriate management of preeclampsia and
eclampsia [14]. Even in countries where the
eclampsia mortality rate remains high, ARF does
not develop frequently: Lopez-Llera et al showed
that mean plasma creatinine was only slightly ele-
vated in pregnant women who died from eclampsia,
and they found evidence of acute tubular necrosis in
only 3 women among 33 who underwent autopsy
examination [15]. In the studies of ARF in gravidas,
however, hypertension or symptoms of pre-
eclampsia were found in a significant proportion of
gravidas, for example 62% [16] and 33% [17].
In our studies, severe preeclampsia was present
in 12 women, 11 of whom had eclampsia (Table 2).
Seizures and hypertension appeared suddenly in 7
patients, and symptoms of toxemia preceded ARF
___________________________
by a few weeks in the 5 other patients. The high
percentage of multiparas (10 of 12 patients) should
be stressed; the mean age of the patients was 27 yr.
Similarly, Kennedy et al indicated that the mean
8 age of their patients with ARE (including post-
49a abortum accidents) was 30 yr [17]. In the series of
41
Ober et a! [7], there were 5 multiparas among the 13
16 pregnant women who died from ARF complicating
24 severe preeclampsia. These authors noted a high in-
cidence of arteriolar and arterial renal changes.
l9C These data suggest that ARF develops in severe
4 preeclampsia preferentially in older gravidas, who
are often multiparas. These cases probably do not
2 represent "true" preeclampsia; they may have un-
detected chronic hypertension or underlying renal
vascular disease, and their remote vascular progno-
sis is therefore poor [18].







































Severe preeclampsia or eclampsia
Abruptioplacentae
Prolonged intrauterine fetal death
Uterine hemorrhage


































Postpartum idiopathic ARF 5 24 2 0 2 35
a Dehydration (2); diabetic ketoacidosis (1); leptospirosis (1); postoperative (1); incompatible blood transfusion (I). The number in
parentheses denotes number of cases.
b One case was associated with renal thrombotic microangiopathy.
Amniotic fluid embolism (1); late interruption of an ectopic pregnancy (1)
Septicemia and septic shock are probably the most
important pathogenetic factors, and therefore early
antibiotic therapy and adequate treatment of shock
should prevent this complication. The same holds
true in other causes of sepsis in pregnancy.
Occasionally ARF may be related to coincidental
factors, for example, drug nephrotoxicity, in-
compatible blood transfusion, bacterial endo-
carditis, or acute glomerulonephritis [9, 12, 13].
Acute renal failure due to factors related to and specific of
pregnancy
Acute renal failure in eclampsia or severe pre-
eclampsia. Acute renal failure may complicate the
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a Including 5 idiopathic postpartum ARFb 20 biopsies and 6 autopsies
Associated in 2 cases with renal thrombotic microangiopathy
Associated with glomerular endotheliosis
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The mechanisms of ARF in preeclampsia are un-
clear. Swelling of the glomerular endothelial cells is
the characteristic renal lesion. It is often stated that
the resulting glomerular capillary obstruction leads
to postglomerular ischemia and acute tubular necro-
sis, and eventually to cortical necrosis. Indeed, gb-
merular endotheliosis was found in almost all cases
of eclampsia [15], but there is no evidence that
these changes were more severe or diffuse in pa-
tients with ARF. Widespread tubular necrosis was
frequently reported in autopsy examinations, but
Sheehan and Lynch stated that "almost all these re-
ports must be discarded as being based on material
from late autopsies" [19]. In their own patients,
they found scanty tubular coagulative necrosis in a
small number of cases. Minimal unspecific tubular
changes were also observed by Ober et al, and tubu-
bar necrosis was present in only one fatal case [7]. It
should be recalled that the role of tubular necrosis
in the pathogenesis of ARF unrelated to nephrotox-
ins remains to be elucidated [20].
Tubular obstruction has been demonstrated re-
cently in various models of experimental ARF [20,
21] but its contribution to acute pigment nephropa-
thy in the human remains to be proven. Intratubular
casts, containing either protein or hemoglobin,
were first reported in toxemia of pregnancy at the
end of the 19th century (see references in Ref. 22).
Approximately 20% of the patients with fatal
eclampsia had intratubular hemoglobin casts, sug-
gesting intravascular hemolysis, but the casts were
not detected in the initial stage of ARF [22]. Intra-
vascular hemolysis has long been recognized, but it
is a rare complication of eclampsia [23]. It may also
be hypothesized that some patients with severe gen-
eralized convulsions develop myoglobinuria, which
may occasionally contribute to ARF.
Brain, Kuah, and Dixon [24] considered intra-
vascular hemolysis occurring in eclamptic women
as evidence of intravascular coagulation. Frag-
mented and distorted red blood cells were found,
indicating microangiopathic hemolytic anemia
(MHA). These authors suggested the hypothesis
that erythrocytes were damaged in the initial phase
of fibrin deposition and microthrombus formation.
Platelets were similarly altered, then removed from
circulation at the site of thrombus formation or by
the reticuloendothelial system, accounting for
thrombopenia. A similar sequence of events could
be involved in various clinical conditions, such as
severe preeclampsia or eclampsia, hemolytic ure-
mic syndrome, or malignant hypertension. In their
review, Brain et al collected 14 previously reported
cases (involving 7 nulliparas); all affected women
had raised blood urea and the onset of MHA always
preceded the appearance of uremia; the maternal
mortality rate was 64% [24]. Disseminated vascular
lesions with arteriolar fibrinoid necrosis and intimal
proliferation were documented in some patients.
Focal renal cortical necrosis was found in 4 pa-
tients. The authors suggested that heparin might be
of value in the treatment of this syndrome, but in
the case they reported, a first episode during a pre-
vious pregnancy had remitted spontaneously [24].
Sheehan and Lynch pointed out, however, that he-
moglobin casts resulting from hemolysis and hemo-
globinuria were not often encountered in endotoxin
shock, where diffuse thrombi were commonly
found. In contrast, disseminated intravascular
thrombi were not found in eclampsia [25]. This
question will be discussed below.
Abruptio placentae and other complications of
pregnancy. In our studies (Table 2), approximately
50% (7/13) of the gravidas with ARF complicating
abruptio placentae had bilateral renal cortical ne-
crosis (BRCN). Fifty percent of the fatal cases of
abruptio placentae were associated with BRCN in
another study [26]. Other complications of preg-
nancy, such as prolonged intrauterine fetal death or
amniotic fluid embolism, may induce ARF [12]. All
these complications are accompanied by coagu-
lation defects, including low plasma fibrinogen lev-
els [27].
Uterine hemorrhage. Hemorrhage and hypoten-
sion were implicated as major etiologic factors in
7% of our patients (Table 2) and in 16% in the series
of Kennedy et a! [17]. They were precipitating fac-
tors in 58% in the study of Smith et al [16]. The
importance of bleeding may be underestimated if it
is not externally obvious. Early and adequate (usu-
ally large) blood transfusion is the best means of
preventing renal functional shutdown [16].
Hypervolemia should protect the parturient
against the effects of blood loss, which may be sub-
stantial even during and after a relatively normal de-
livery. It has been suggested that renal function in
toxemic women is highly sensitive to blood loss.
For example, Smith et al noted that among 18 tox-
emic women, ARF seemed to be precipitated by
hemorrhage in 11 [16]. Various mechanisms may
explain this hypersensitivity. Preeclamptic women
have lower plasma volume and renal blood flow,
and higher pressor responsiveness to norepineph-
rine and angiotensin II than do normotensive gravi-
das. It has been shown that placentae of pre-
eclamptic patients release less prostaglandin than
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do those of normal gravidas, and relative prosta-
glandin deficiency may be involved in the hyper-
sensitivity to hemorrhage [28]. Last, coagulation
changes observed in pregnancy (see below) may fa-
cilitate the development of ARF. It is worth noting
that none of our 4 patients with hemorrhage and
ARF were toxemic. Two of them developed BRCN,
which would appear to be a high incidence. In the
study of Smith et al [16], hypertension and bleeding
were frequently associated in women with BRCN,
but in their case 7, antepartum hemorrhage in the
absence of preeclampsia was the only triggering fac-
tor detected.
Bilateral renal cortical necrosis
It is clear that pregnant women with ARF are at
high risk of BRCN. In the studies of Smith et al, 8
cases of BRCN (27%) were recognized; all affected
women died [16]. In India, BRCN was present in
37.8% of the women with ARF in late pregnancy
[29]. In our study, the incidence was 33%; one pa-
tient developed panhypopituitarism, which was
probably related to concomitant pituitary necrosis,
and necessitated continuous hormonal therapy.
Patchy cortical necrosis with partial or nearly com-
plete recovery of renal function may be overlooked
in surviving patients if adequate investigations are
not performed. The real incidence of BRCN may
therefore be underestimated in the studies where
only autopsy data were available.
Bilateral cortical necrosis tends to occur more of-
ten in certain obstetric complications. The in-
cidence is high in abruptio placentae (see above).
Eighty percent of fatal BRCN were associated with
uteroplacental apoplexy in the Boston study [7]. In
our studies, prolonged intrauterine fetal death also
carries a high risk of BRCN, because this complica-
tion was documented in 5 of 6 cases (Table 2). In
contrast, the incidence is relatively low in severe
preeclampsia (Table 2). Sheehan and Lynch in-
dicated that it was noted in only 2% of gravidas with
fatal preeclampsia [26].
Ober et al found that BRCN occurred mainly in
pregnant women over 30 yrs of age with coexistent
nephrosclerotic changes [7], but it may develop in
younger subjects, as shown in previous studies [4,
16] and in our present study in which 5 patients
were under 25 yr of age. It is generally accepted that
toxemic symptoms often, but not invariably [16]
precede BRCN. Kleinknecht et al, however, noted
that toxemic symptoms were less common in pa-
tients with BRCN than they were in those with re-
versible ARF and full recovery. In addition, they
showed that in women with BRCN, acute renal fail-
ure appeared earlier in gestation [4]. The analysis of
the present series confirmed our previous findings
[4], but the early occurrence of BRCN was mainly
due to the early ARF in women with prolonged in-
trauterine fetal death in whom BRCN was almost a
constant occurrence (Table 2). Data from patients
with ARF and abruptio placentae are analyzed in
Table 3. There is no striking difference between the
two groups, except that polyuric ARF was not ob-
served in BRCN; women with BRCN were not old-
er than those with full recovery. It is difficult to as-
sess the true incidence of toxemia in patients with
abruptio placentae because many are emergency
admissions, and a normal or low blood pressure at
that time does not exclude a previous short toxemic
period.
The diagnosis of BRCN should be suspected in a
pregnant woman, particularly when ARF develops
before the 30th week of gestation, even in the ab-
sence of toxemic symptoms, and when the oliguric
or anuric stage is prolonged beyond 10 days [4].The
positive diagnosis is based on renal biopsy and/or
selective arteriography data [4].These two methods
may provide information on the extent of the corti-
cal necrosis [4], differentiating extensive BRCN
characterized by a large percentage of destroyed







Age,yr 29.2 l.8 30.4 l.8
Time ofgestation, wks 32.8 l.5 34.3 l.8
Nullipara 1 0
Toxemia 2 2
Polyuric ARF 4 0
Epsilon aminocaproic acid administration 3 5
Thrombocytes, x l0, per mm3 138 28a 65 26a,
° Values are the means SEM.
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Fig. 1. Outcome of 13 patients with obstetric bilateral renal cortical necrosis. HD is hemodialysis.
glomeruli, and the lack of cortical nephrogram,
from patchy cortical necrosis where a larger per-
centage of glomeruli are spared and the cortical
nephrogram is striated and heterogeneous. Cortical
calcifications may be seen on X-rays after a few
weeks [4, 26].
It is well recognized that patients with BRCN
may slowly recover renal function [30]. Renal func-
tion may improve until the third year after the onset
[4, 31]. In the patient described by Effersoe
Raaschou, and Thomsen, BRCN was followed by
two uneventful pregnancies [31]. In most patients
who survived the acute phase of ARF, residual re-
nal function resumed (Fig. 1). Permanent hemo-
dialysis was required after the acute phase in only
one patient. Chronic dialysis may occasionally be
temporarily discontinued. Such a course is illus-
trated in Fig. 1: in two patients hemodialysis was
performed for 1 and 4 months, then interrupted for 5
and 9 yr, respectively, because renal function im-
proved and stabilized. Unfortunately, it sub-
sequently deteriorated and maintenance hemo-
dialysis had to be again instituted. Successful renal
transplantation has been reported [4], but some au-
thors have pointed out the high risk of acute rejec-
tion in patients with previous BRCN [32].
Acute renal failure in acute fatty liver of pregnancy
Acute fatty liver is a rare complication of preg-
nancy; approximately 60 cases have been reported
so far [33—35].
Typically the first manifestations (fever, nausea,
vomiting, and abdominal pain) appear in the pre-
partum or in the early postpartum period, less often
in the third trimester of pregnancy. They are rapidly
accompanied by jaundice, which is characterized
by normal serum alkaline phosphatase, minimal in-
crease in serum transaminase, and, occasionally,
increased serum amylase activities [35]. Toxemia
was reported in about 20% of the cases [35]. Patho-
logic liver changes are characterized by micro-
vacuolar fatty infiltration with centrilobular domi-
nance. There is no loss of lobular structure, and no
significant necrosis or cellular infiltrate. Fatty liver
of pregnancy has been reported following tetracy-
cline or related antibiotic compound therapy [36].
The incidence of ARF in this condition is high,
reaching 60% or more [33, 35]. The mortality rate is
as high as 70 to 75% for both the fetus and the
mother [33, 35], but it appears to be primarily the
result of hepatic rather than renal failure. ARF may
occur either early or late in the preterminal course.
The prognosis has improved in the patients treated
since 1970 [37—39].
Various, and often slight, renal histopathologic
changes have been described. Kidney structure
may be within normal limits [35, 40]. Fine fatty vac-
uoiization of the tubular cells was noted in several
cases. These lesions may be slight and were found
in patients with normal renal function [41]. Focal
tubular necrosis or nonspecific changes consistent
with tubular regeneration were also detected [42].
Occasionally, glomerular lesions were observed: in-
traglomerular thrombi [43] suggesting intravascular
coagulation, or membranoproliferative changes
[44]. Morrin et al [45] described, by light and elec-
10.0
1 2 3 6 9 1 2 3 4 5 6 7 8 9 ioThs 16
months years
184 Grünfeld et a!
tron microscopy, segmental occlusions of capillary
lumina by fibrin-like material in about 50% of the
glomeruli; the subendothelial spaces were promi-
nent and appeared to be occupied by a fibrillar ma-
terial. These changes resemble those reported in
toxemia or in the hemolytic uremic syndrome [45].
It should be noted that there was no pathologic evi-
dence of acute fatty liver in the case studied by
Morrin et al because liver biopsy was normal but
was performed late in the course [45]. This empha-
sizes the need of adequate kidney and liver biopsy
data in this syndrome. Jaundice is frequently found
in ARF from other causes in pregnancy: of the 57
patients in our study, 20 had jaundice (Table 1). The
diagnosis of fatty liver should therefore be based on
unquestionable pathologic findings.
The pathogenesis of ARF in acute yellow atrophy
of liver in pregnancy is unknown. Shock is not a
constant finding. Acute pancreatitis was possibly a
precipitating factor in some cases [35]. Abnormal-
ities suggestive of disseminated intravascular coag-
ulation have been detected in patients investigated
since 1970 [35, 38, 40]. Intraglomerular deposition
of fibrin has been demonstrated in some patients
[38, 45], but no case of BRCN has so far been re-
ported. Fatty liver of pregnancy shows some simi-
larities with Reye's syndrome, or fatty change with
encephalopathy, observed in children. In this syn-
drome, serum transaminase activities are increased,
and central nervous system disturbances are promi-
nent. In addition, ARF is rare in Reye's syndrome,
although the kidney shows fatty changes [46]. In
contrast, renal failure has been more frequently
noted in children with encephalopathy and hepatic
dysfunction, a syndrome differing from Reye's syn-
drome by the absence of diagnostic liver changes
[47]. Finally, many features of ARF in fatty liver
resemble the so-called "hepatorenal syndrome" re-
ported in various hepatic disorders, in which hemo-
dynamic factors are probably prominent.
Idiopathic postpartum acute renal failure
The first cases of idiopathic postpartum ARF
were published during 1966 to 1968 under various
labels [12, 26], but occasional cases had possibly
been reported previously (see references in Ref. 26,
and case 8 in Ref. 16). It is not clear whether this
entity was misdiagnosed in the past or is a new dis-
ease [26]. Recent drugs used at delivery, such as
ergot alkaloids, were incriminated in its causation,
but without conclusive evidence. Thirty cases were
reviewed in 1976 by Schoolwerth et al [5]. Twenty-
one additional cases were found in the literature
[26, 48—59])
Typically, the syndrome begins 1 day to several
weeks postpartum. The term "late puerperal renal
failure" is therefore inappropriate [26]. The preg-
nancy had usually been uneventful, without hyper-
tension, in a previously healthy woman. In many
patients the initial symptoms simulated a flu-like
syndrome. Subsequently, severe, often anuric,
ARF developed rapidly. Initially, the blood pres-
sure was usually normal or slightly elevated, but in
many cases hypertension appeared later in the
course. Microangiopathic hemolytic anemia (that
is, anemia, numerous schistocytes, high reticulo-
cyte count, and low serum haptoglobin level) was
documented in many patients, but not in all [5]. The
term "postpartum hemolytic uremic syndrome" is
therefore appropriate only in cases with MHA.
Thrombocytopenia was found less frequently. Two
thirds of the patients died or required chronic dial-
ysis, but a few women had recovery of renal func-
tion [5].
Besides the idiopathic postpartum ARF as de-
fined above, many atypical cases are described un-
der the same term, and therefore evaluation of the
therapy used is difficult or impossible.
(1) Time of onset. In most instances, ARF occurs
either early, within a few days, or slightly later,
within a few weeks, postpartum [5]. In our study
(Table 2), ARF developed within 1 day postpartum
in two women, after a normal pregnancy; both had
cortical necrosis (see also cases 6 and 8 in Ref. 16).
ln the three others, renal failure appeared later and
renal thrombotic microangiopathy was found on the
biopsy specimen.
In a few women [51, 60], the syndrome began
during pregnancy. At the other extreme, in several
other patients it occurred at 5 [60], 6, and 7.5
months postpartum [61]. It is unknown whether in
the latter cases pregnancy was involved. Recurrent
postpartum hemolytic uremic syndrome (HUS) has
been reported [57]. Similarly, severe preeclampsia
with MHA and ARF may recur in subsequent preg-
nancies [24].
'Since the submission of the manuscript, three additional cas-
es of postpartum hemolytic uremic syndrome were reported by
Segonds et a! (Clin Nephrol 12:229—242, 1979). The authors em-
phasize the possible occurrence of slight hypocomplementemia,
an abnormality already observed in some patients with HUS. On
the other hand, Hensby et a! (Lancet 2:748, 1979) found a defi-
ciency in prostacyclin production and a platelet unresponsive-
ness to exogenous prostacyclin in a 45-yr-old female patient with
severe PIT. Prostaglandin metabolism requires further study in
postpartum HUS.
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(2) Hypertension. Hypertension or toxemia pre-
ceded postpartum ARF in several cases [48, 52, 54,
55, 60, 62]. We pointed out above that severe pre-
eclampsia may include MHA [24]. Thus, it may be
difficult to differentiate on clinical grounds severe
preeclampsia with renal failure and MHA from
idiopathic postpartum ARF. In addition, eclampsia
may suddenly appear within 48 hr postpartum, and
may be complicated with ARF.
In some reports, severe hypertension was noted
initially in the course of postpartum ARF [48, 51,
55, 58, 60]. In these cases, the possibility of malig-
nant nephrosclerosis might be considered, because
malignant hypertension in nonpregnant subjects
may be accompanied by MHA and uremia.
(3) Extrarenal involvement. Thrombotic throm-
bocytopenic purpura (TTP) may develop during
pregnancy [26, 63, 64] or even in the postpartum
period [65, 66], and renal function may be impaired.
Idiopathic postpartum ARF may mimic TTP be-
cause multisystem [48] or, more often, central ner-
vous system involvement (leading to lethargy,
coma, or grand mal seizures) [51, 57, 62] have been
described. The high incidence of cardiac failure was
stressed by Robson et al [67]. As in TTP, autopsy
revealed disseminated thrombi in the case studied
by Rosenmann et al. In this case, fatty liver of preg-
nancy was also found and was possibly related to
tetracycline therapy [62]. Extrarenal foci of arteri-
olar necrosis were also found by Churg et al [61].
(4) Renal pathology. Histopathologic findings
are heterogeneous. Scattered areas of cortical ne-
crosis may be found. Some pathologists have
stressed the importance of the arterial/arteriolar
changes suggestive of nephrosclerosis (hence the
term "postpartum nephrosclerosis") [5], whereas
others [67] pointed out the peculiar lesions sugges-
tive of thrombotic microangiopathy, involving gb-
merular capillaries and arterioles, as described by
Symmers in 1952. The latter type of lesions is well
illustrated by the case reported by Rosenmann et al:
the glomerular endothelial cells were enlarged; fi-
brin thrombi were found in many afferent arterioles
and glomeruli; obstruction of glomerular capillaries
resulted from endothelial swelling and large sub-
endothelial deposits which were granular and en-
meshed with strands of fibrillar material with the
characteristic periodicity of fibrin; identical depos-
its were detected in afferent arterioles; and last,
there was increased prominence of the mesangial
areas [62]. These changes are similar to those found
in the hemolytic uremic syndrome in young children
[68]. On the other hand, vascular lesions character-
istic of malignant nephrosclerosis (or of kidney in-
volvement in scieroderma with ARF) were also of-
ten described [5, 52]. Glomeruli were ischemic with
wrinkled basement membranes; when glomerular
necrosis was present, it was considered to be the
extension of the arteriolar fibrinoid necrosis. The
vascular lesions also involved the intralobular arter-
ies.
So far, it is unclear whether these two types of
lesions correspond to different entities or whether
they represent successive stages of the same dis-
ease. The time of the renal biopsy may be critical,
but the data available in the literature do not pro-
vide definite information in this regard [50]. In our
experience, the renal lesions found in idiopathic
HUS in adults whose blood pressure was initially
normal or slightly increased [68] diffusely involved
arterioles and intralobular arteries in nearly all cas-
es. The glomerular changes, however, were of ei-
ther type—that is, microangiopathic (Fig. 2) as in
children, or ischemic (Fig. 3)—even early in the
course of the disease; the mean age of the patients
with ischemic changes was higher. When late ana-
tomical data were obtained from patients with irre-
versible renal failure, microangiopathic glomerular
lesions could still be present; but in most cases,
changes suggestive of glomerular ischemia were
found as in nephrosclerosis (D. Droz, D. Ganeval,
and R. Habib, unpublished results). Among the four
cases of renal thrombotic microangiopathy included
in the present study, one was complicated by pro-
longed intrauterine fetal death; the 3 others oc-
curred in the postpartum period; in all, glomerular
changes were prominently ischemic.
Heptinstall pointed out that the degree of vascu-
lar involvement was of predictive value in the he-
molytic-uremic syndrome [70]. Recently, Morel-
Maroger et al showed that the degree of arterial in-
timal thickening was significantly less severe in
adult patients with hemolytic-uremic syndrome and
relatively good outcome than it was in those with
poor outcome, whereas there was no difference in
the overall severity of the glomerular changes be-
tween the two groups [58]. They included in their
study, however, many patients who initially were
severely hypertensive.
Immunofluorescent study usually revealed fibrin
and occasionally /31C globulin in glomeruli and arte-
rioles [5, 52, 58]. Focal staining with anti-IgG and
1gM antisera was found in some patients [5], but
glomeruli generally did not stain, except in minute
amounts in rare cases [61, 62].
A relatively high incidence of severe postbiopsy
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Fig. 2. Glomerular involvement of microangiopathic type in a
woman with postpi!l HUS. The tuft is enlarged. Glomerular cap-
illary walls are strikingly thickened with "double contour," and
fibrin thrombi are present in some capillary lumina. Note
thrombus in the juxtaglomerular arteriole. (X450; courtesyof Dr.
D. Droz).
hemorrhage was reported [58], especially when
heparin therapy was instituted a few days after re-
nal biopsy [58], but also in hypertensive patients who
did not receive heparin [60, 61]. The indication for
renal biopsy should be carefully discussed in each
case, with regard to its value for diagnosis and ther-
apeutical decision. Renal biopsy is undoubtedly
necessary in patients who do not have MHA. In
contrast, in patients with unequivocal HUS, the
clinical usefulness of renal biopsy may be ques-
tioned (see below).
(5) Oral contraceptives. Tobon [71], then Brown
et a! [71] first described the occurrence of the hemo-
lytic-uremic syndrome in women taking oral con-
traceptives. Severe hypertension is often present
[70], but the syndrome may develop in women with
normal blood pressure [5, 71]. Among those with
late postpartum ARF, some were taking con-
traceptives [50, 58, 61, 73]. It is not clear whether in
these cases the HUS should be ascribed to preg-
nancy or to the oral contraceptive agents.
Fig. 3. Glomerular ischernic changes in a woman with idiopathic
postpartum HUS. The glomerulus shows ischemic changes with
diffuse wrinkling of the glomerular basement membranes. (X450;
courtesy of Dr. D. Droz).
Renal histopathologic changes in postpill hemo-
lytic-uremic syndrome were succinctly described
[72]. Renal changes were considered compatible
with malignant nephrosclerosis [5] or with throm-
botic microangiopathy [71]. We observed 5 women
with this syndrome (D. Ganeval and D. Droz, un-
published data); 3 died and the other 2 required pe-
riodic maintenance hemodialysis. Renal biopsy was
performed in all; in 4 of them it showed changes of
glomerular capillaries resembling those found in the
HUS in young children (Fig. 2), but arteriolar le-
sions were more diffuse.
There is no good evidence that postpill and post-
partum renal failure share similar pathogenetic
mechanism(s). Cases were reported in which hyper-
tension and severe renal failure followed oral con-
traceptive administration, whereas pregnancies had
been uneventful in these women [74, 75]. Pritchard
and Pritchard noted a similar dissociation between
pregnancy-induced hypertension and postpill hy-
pertension [76]. A genetic predisposition may also
be involved: hemolytic-uremic syndrome [77] and
TTP [78] have been reported in siblings taking oral
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contraceptives. In two sisters, TTP occurred during
late pregnancy, 2 years apart [64]. The familial oc-
currence of hemolytic-uremic syndrome has been
emphasized repeatedly [79]. In the unique kindred
described by Grottum et al as "immunological he-
reditary nephropathy" with MHA, 3 women devel-
oped progressive renal failure during pregnancy
[80].
(6) Therapy. Is heparin therapy beneficial in the
management of postpartum ARF? From the review
of Schoolwerth et al [5] and from subsequent data,
it is apparent that heparin failed to improve renal
function in many patients [49, 51, 55, 56]. Most
"positive" reports contain one single successful
case [5, 52], and "negative" results have probably
not been published. Only one paper [60] includes 5
patients; they were treated by several drugs, includ-
ing heparin; only one death occurred, the 4 other
women recovered renal function. The cases report-
ed were quite uncommon, however: 4 of the pa-
tients had toxemic symptoms and were severely hy-
pertensive in the early stage of ARF; in 3, severe
uterine and/or postrenal biopsy hemorrhage was
noted and may have contributed to the severity of
ARF [60]. It is therefore difficult to evaluate the
beneficial effect of heparin. It should also be re-
called that there is no evidence that heparin therapy
is beneficial in the hemolytic-uremic syndrome in
children [81].
Morel-Maroger et a! proposed more vigorous
heparin therapy in patients with less severe vascu-
lar lesions because, in their studies, these patients
had a better prospect of renal recovery [58]. Their
study contains no evidence that heparin therapy
was beneficial in the 4 patients with postpartum
HUS: all 4 were treated, with success in only 2 [58].
In late cases, with extensive and irreversible vascu-
lar changes, renal biopsy was considered dan-
gerous, and anticoagulation unwarranted [58]. In
our study, none of the 4 patients with HUS and re-
nal thrombotic microangiopathy was treated with
heparin, yet 2 had a good outcome with complete or
partial recovery.
Thus, it may be reasonably questioned whether
heparin is of value in postpartum ARF and whether
conservative management, including dialysis and
antihypertensive drugs when necessary, is not a
better choice. The latter therapeutic approach is
reasonable in hypertensive patients with severe
vascular changes in the renal biopsy specimen. In
contrast, in women with ARF and unequivocal
MHA, in the absence of severe hypertension, hepa-
rin therapy may be contemplated. Two possibilities
are open: either to perform renal biopsy to evaluate
whether or not heparin therapy is indicated (the risk
of renal bleeding from the biopsy site during heparin
therapy has to be considered), or to institute rapidly
heparin therapy without renal biopsy (with the risk
of including unproven cases).
Fibrmolytic therapy has also been tried, without
significant effect on renal function (see Eisenger in
Refs. 5, 56). The therapeutic approaches attempted
in TTP may be aplied to postpartum HUS. Adminis-
tration of antiplatelet agents was advocated in TTP
[82]. Thus, Thorsen et al found a beneficial effect of
dipyridamole and aspirin in 2 cases of "hemolytic
uremic syndrome"; however, one of them had no
renal failure. Both patients had severe pre-
eclampsia, possibly responsible for the hematologic
changes, and spontaneous recovery could have
been expected after delivery [83]. Plasmapheresis
or rather plasma infusion, was recently advocated.
In a woman with TTP appearing during pregnancy,
plasma infusion had a beneficial effect on the hema-
tologic and renal abnormalities [84].
Bilateral nephrectomy was performed in some
patients [5, 50, 58]. MHA may clear following ne-
phrectomy, as it may occur in idiopathic HUS. Ne-
phrectomy is highly valuable in women with pro-
gressively intractable hypertension [59], but it
should be reserved for these patients, because renal
function has recovered partially in occasional cases
after a long period of dialysis, as in idiopathic HUS
and other vascular renal diseases [86]. Successful
renal transplantation was performed in patients
with postpartum ARF without recurrence of the dis-
ease [50, 55, 58] (2 cases in the present series).
Role of intravascular coagulation in acute renal failure
during pregnancy and the postpartum period
Normal pregnancy is accompanied by an en-
hanced capacity to produce fibrin (increased levels
of plasma fibrinogen, and of factors VII, VIII, and
X), whereas removal activity is depressed. The de-
creased fibrinolytic activity returns to normal with-
in 0.5 to 1.0 hour after placental delivery. In pre-
eclampsia, a reduced number of circulating plate-
lets, increased levels of serum fibrin degradation
products (FDP), and enhanced thrombin activity
are commonly found. In addition, fibrinolytic activi-
ty returns to normal several days after placental de-
livery [86]. Intravascular fibrin deposition was
found in renal glomeruli of preeclamptic women (at
least in severe forms). In abruptio placentae and
prolonged intrauterine fetal death, the fibrinogen
concentration at term was below the normal value,
188 Grünfeld et a!
factors V and Viii levels were markedly reduced,
and FDP levels were elevated but no evidence of
systemic fibrinolysis was observed [27]. Similarly,
severe postpartum hemorrhage and amniotic fluid
embolism may also lead to the defibrination syn-
drome [27]. The release of thromboplastin from a
placental or amniotic site has been proposed as the
triggering factor of these clotting disorders.
The coagulation disturbances observed in normal
gestation and especially in complicated pregnancy
have led to the hypothesis that these disorders may
facilitate the development of obstetric ARF. The
high incidence of BRCN further suggested that in-
travascular coagulation phenomena are involved in
the pathogenesis of obstetric ARF. The con-
sequences of intravascular coagulation and its ex-
tent (from localized to disseminated changes) de-
pend on several factors: the triggering event, the
duration and severity of the clotting disturbances,
the presence or absence of endothelial damage, the
rate of organ blood flow, and the rate of clearing of
the various activated components of the clotting
system. This might explain the wide clinical spec-
trum of renal changes found in pregnancy, from gb-
merular endotheliosis to BRCN and postpartum
ARF.
This unifying concept is further supported by ex-
perimental and pathologic data. It has been stated
repeatedly that eclampsia, BRCN, and other acute
fatal complications of pregnancy represented the
clinical counterpart of the experimental Shwartz-
man reaction in which bilateral renal cortical necro-
sis is the main feature [87]. In contrast to non-
pregnant animals, only one injection of endotoxin
was required to elicit the generalized reaction in
pregnant rabbits. Kincaid-Smith concluded from
her pathologic studies that similar primary renal le-
sions were found and a similar pathogenetic mecha-
nism was involved in preeclampsia, postpartum be-
nign ARF, and postpartum irreversible ARF, the
only difference being in the extent and severity of
the pathologic changes [88].
In contrast, it should be recalled that clinical data
do not convincingly demonstrate the primary role of
disordered coagulation in obstetric ARF. There is
no evidence that in preeclampsia, abruptio pla-
centae, or prolonged intrauterine fetal death, coagu-
lation abnormalities are more severe in women with
ARF than in those without it. The severity of ARF
is not closely related to the intensity of coagulation
disturbances. In patients with postpartum ARF.
clotting studies were often incomplete, but data
consistent with intravascular coagulation were
scarce, whereas renal failure was frequently irre-
versible [5]. In obstetric patients, Chugh et al found
that disseminated intravascular coagulation (DIC)
was seen more frequently in cases of acute tubular
necrosis than in cortical necrosis [29]. The in-
cidence of BRCN in obstetric patients with ARF
(including early postabortum) was identical in wom-
en with and without DIC [89]. Some results suggest,
however, that coagulation phenomena may contrib-
ute to cortical necrosis. Gravidas with BRCN had a
significantly lower plasma fibrinogen and slightly
lower thrombocyte count than did pregnant women
with ARF who recovered fully [4]. In the short se-
ries of women with abruptio placentae, we con-
firmed that platelet counts were lower (but not sig-
nificantly so) in those with BRCN (Table 3). Wardle
showed that experimental placental abruption in the
rabbit was followed by a defibrination syndrome,
but that renal cortical necrosis only resulted when
fibrinolysis was further inhibited by epsilon-amino-
caproic acid [90]. In this regard, it is worth noting
that this drug, with or without fibrinogen infusion,
had been administered to 10 of our patients who
subsequently developed BRCN. In the group with
abruptio placentae, however, the administration of
the drug was not significantly more frequent in gray-
idas with BRCN (Table 3).
The use of heparin is still controversial, and there
is no evidence that this drug has a preventive effect
in pregnant women at high risk of ARF. Pritchard et
al used magnesium sulfate, antihypertensive drugs,
and adequate obstetric management in the treat-
ment of eclamptic women, mainly primiparas. No
maternal death occurred, and only one case of ARF
was reported among 161 patients [3, 14]. These au-
thors do not therefore advocate heparin therapy
[91]. The usefulness of heparin may be questioned
in preeclamptic multiparas in whom chronic vascu-
Jar renal disease is often present and in whom se-
vere ARF with BRCN might be more frequent. Ob-
vious dangers, however, outweigh any theoretic
and unproven benefits. The use of heparin should
also be viewed with caution in abruptio placentae
and in prolonged intrauterine fetal death. In some
cases of defibrination, it may aggravate the condi-
tion or cause severe hemorrhage from the uterus or
in the central nervous system if high blood pressure
is present [27].
It is still unclear whether coagulation changes
represent the primary event in ARF related to some
complications of pregnancy. Some authors [23, 25]
stressed the primacy of vasospasm in preeclampsia
and of endothelial lesions in postpartum ARF. A
striking feature in BRCN was the absence of renal
thrombi in specimens obtained early in the course,
whereas late specimens contained thrombi [25].
Endothelial damage or disruption probably initiated
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platelet adherence and fibrin deposition [23, 25],
phenomena which may play an aggravating role in
tissue ischemia. The data of Raij, Keane, and Mi-
chael may be relevant in this regard. These authors
induced unilateral renal Shwartzman reaction and
showed that the initial event in the genesis of corti-
cal necrosis was a specific local effect of endotoxin
on the vascular endothelium [92]. These data sup-
port previous results suggesting that thrombi form
in situ in areas of endothelial damage.
Dialysis in obstetric ARF
Both peritoneal dialysis and hemodialysis have
been used in gravidas with ARF. Many prefer pen-
toneal dialysis or consider the procedure safe pro-
vided "the catheter is inserted high in the abdomen
under direct vision through a small incision" [93].
During hemodialysis, anticoagulation and fluid ba!-
ance should be carefully monitored. Forty-two pa-
tients in our study were treated by hemodialysis,
but none before delivery.
In some cases, the onset of ARF preceded the
delivery of a live infant [6, 94]. If the conceptus is
mature, it should be delivered as soon as the
mother's condition has been stabilized [93]. It is of-
ten stated that the prognosis for the fetus is worse
than that for the mother with ARF [93]. In our
study, the 8 cases of prepartum ARF were associat-
ed with 2 fetal deaths and no maternal death.
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